Good post.
yes humility is needed, Roche certainly doesn possess this quality. a lot of shareholders are down from either purchase price or loss of profits from the peak.
Your clarity of where we are is exactly what happens at this stage of development.
patience required.
mick
ADN new valuation, page-26
Add ADN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $24.00M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.6¢ | $4.903K | 748.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 17955019 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 9103740 | 27 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| ADN (ASX) Chart |